BioBridgeXAll companies

Synapticure, Inc.

Biotechnology company · Chicago, Illinois, United States

Synapticure, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2019. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.9 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Synapticure at a glance

Typebiotechnology company
HeadquartersChicago, Illinois, United States
Earliest incorporation on record2019
Employees (self-reported, 2025)1
SEC CIK2038193

What does Synapticure do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $3.9 million in total (2022 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $40.1 million sold (2024).

Frequently asked questions about Synapticure

Where is Synapticure headquartered?

Synapticure, Inc. is headquartered in Chicago, Illinois, United States.

What does Synapticure do?

Synapticure, Inc. is a biotechnology company.

When was Synapticure founded?

The earliest incorporation on record for Synapticure, Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences